Skip to main content
Monday, November 16, 2026Nov 16

After bankruptcy filing, Purdue Pharma may not be off hook

In this August 2018 file photo, family and friends who have lost loved ones to OxyContin and opioid overdoses protest outside Purdue Pharma headquarters in Stamford, Conn. OxyContin maker Purdue Pharma made headlines when it reached a landmark settlement with Oklahoma over the toll the opioids crisis has taken on that state. Attempts to do the same in a major federal case in Ohio are proving more difficult. (AP Photo/Jessica Hill, File)
In this August 2018 file photo, family and friends who have lost loved ones to OxyContin and opioid overdoses protest outside Purdue Pharma headquarters in Stamford, Conn. OxyContin maker Purdue Pharma made headlines when it reached a landmark settlement with Oklahoma over the toll the opioids crisis has taken on that state. Attempts to do the same in a major federal case in Ohio are proving more difficult. (AP Photo/Jessica Hill, File)

Purdue Pharma filed for bankruptcy in the first step in a complex, multibillion-dollar plan by the maker of OxyContin to settle thousands of lawsuits brought against it by state and local governments over the nation’s deadly opioid disaster.

The company and members of the Sackler family, which owns it, expressed sympathy but not responsibility.

“Like families across America, we have deep compassion for the victims of the opioid crisis,” family members said in a statement, calling the settlement plan a “historic step towards providing critical resources that address a tragic public health situation.”

But the bankruptcy filing, made late Sunday, may not get either the drugmaker or the Sacklers off the legal hook.

About half the states and lawyers representing at least 1,000 local governments have agreed to the tentative settlement, which the company says could be worth $10 billion to $12 billion over time and would include at least $3 billion from the Sacklers.